State Street’s Pandion Therapeutics Inc. Common Stock PAND Stock Holding History

State Street’s Portfolio PAND Stock Details PAND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-189,721	Closed	-$11.4M	–	4539
2021 Q1	$11.4M	Buy	189,721 +90,048	+90%	+$3.26M	﹤0.01%	2677
2020 Q4	$1.48M	Buy	99,673 +33,390	+50%	+$465K	﹤0.01%	3468
2020 Q3	$760K	Buy	+66,283	New	+$1.13M	﹤0.01%	3503

State Street's PAND Position: Q2 2021 in Review

State Street sold out of Pandion Therapeutics Inc. Common Stock (PAND) in Q2 2021, closing a stake of 189,721 shares — an estimated $11.4M sold.

State Street first reported a position in PAND in Q3 2020 and held it in 3 quarters. The position peaked at $11.4M in Q1 2021. 0 funds tracked by Wall St. Rank hold PAND as of Q2 2021.

State Street reported no remaining Pandion Therapeutics Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
State Street sold 189,721 Pandion Therapeutics Inc. Common Stock shares in Q2 2021, an estimated $11.4M.
State Street first reported a position in Pandion Therapeutics Inc. Common Stock in Q3 2020 and held it in 3 quarters.
State Street's Pandion Therapeutics Inc. Common Stock position peaked at $11.4M in Q1 2021.
0 funds tracked by Wall St. Rank held Pandion Therapeutics Inc. Common Stock as of Q2 2021.

Based on State Street's 13F filing for Q2 2021, filed 16 Aug 2021.